Detection of Amplification of Her2 Fluorescent in Situ Hybridization (FISH) in Breast Tissue Sections

Completed

Conditions studied: Breast Cancer

In brief

The purpose of the study is the identification of amplification level in human breast tissue. The imaging system is intended for diagnostic use as an aid to the pathologist in the detection, counting and classification of Her2 FISH stained tissue samples.

Key facts

Study ID

NCT01066507

Run by

Applied Spectral Imaging Ltd.

People needed

126

Starts

2008-07-01

Expected to finish

2010-01-01

Last updated by the study team

2010-02-10

Who can join

Age: 21 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Well stained breast tissue slides with bright Her2 signals

You may not qualify if…

• Very old slides that were already bleached

Where it is running

• PLUS Diagnostics — Lakewood, New Jersey, United States
• Scott & White Hospital, Texas — Temple, Texas, United States
• Sheba Medical Center, Pathology Dep. — Tel Aviv, Israel

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.